Biography

• Richard Martin, Ph.D.
  

  Vice President of Chemistry
  
  
  Dr. Martin has over 20 years of research and development experience in the fields of antibacterial, inflammation, oncology, antiviral, antifungal, cardiovascular and metabolic diseases as well as sexual dysfunction. Dr. Martin oversees the chemistry, manufacturing and supply chain activities for the company, which he joined as Vice President of Chemistry in March 2010. Previously, Dr. Martin was the Senior Director of Chemistry, founding partner and investor of RetroVirox. Dr. Martin was also with X-Ceptor therapeutics as the Director of Chemistry, which was acquired by Exelixis in 2004 for their valuable metabolic disease programs.
  
  Dr. Martin obtained his Ph.D. from the University of Toronto and pursued postdoctoral studies at The Scripps Research Institute in San Diego. He has over 30 patent applications, 13 of which have been granted in the United States and several publications in peer-reviewed journals.